年間 6 号発行
ISSN 印刷: 1045-4403
ISSN オンライン: 2162-6502
Indexed in
Cyclic Peptides for Protein−Protein Interaction Targets: Applications to Human Disease
要約
Protein−protein interactions (PPIs) represent a significant portion of functionally relevant biological interactions, and therefore potential therapeutic targets. Small molecules were traditionally used to target PPIs. However, many PPI surfaces lack binding pockets due to their large and flat structures. Antibodies can also be used to modulate PPIs, but they are expensive and not cell permeable. Linear peptides are less expensive to produce than antibodies and are generally more selective than small molecules, but they are limited by decreased stability and poor permeability. Modified peptides (peptidomimetics, e.g., cyclic peptides) can overcome these obstacles. Advantages of using cyclic peptidomimetics to modulate PPIs derive from their conformational constraint, which supports target specificity, cell permeability, and metabolic stability. Methods for rational design coupled with high-throughput techniques continue to support advances in the field. Further development of cyclic peptidomimetics to modulate PPIs will improve treatment of human diseases, such as cancer, infection, neurodegeneration, and autoimmunity. Here we describe several cyclic peptidomimetics that are currently used as drugs and many potential cyclic peptides PPI inhibitors in different stages of pre-clinical and clinical development. Further development of cyclic peptidomimetics to modulate PPIs will continue to improve treatment of human diseases, such as cancer, infection, neurodegeneration, and autoimmunity.
-
Schneider Jeffrey A., Craven Timothy W., Kasper Amanda C., Yun Chi, Haugbro Michael, Briggs Erica M., Svetlov Vladimir, Nudler Evgeny, Knaut Holger, Bonneau Richard, Garabedian Michael J., Kirshenbaum Kent, Logan Susan K., Design of Peptoid-peptide Macrocycles to Inhibit the β-catenin TCF Interaction in Prostate Cancer, Nature Communications, 9, 1, 2018. Crossref
-
Morrison Michael J., Boriack-Sjodin P. Ann, Swinger Kerren K., Wigle Tim J., Sadalge Dipti, Kuntz Kevin W., Scott Margaret Porter, Janzen William P., Chesworth Richard, Duncan Kenneth W., Harvey Darren M., Lampe John W., Mitchell Lorna H., Copeland Robert A., Jeltsch Albert, Identification of a peptide inhibitor for the histone methyltransferase WHSC1, PLOS ONE, 13, 5, 2018. Crossref
-
Geranurimi Azade, Cheng Colin W. H., Quiniou Christiane, Zhu Tang, Hou Xin, Rivera José Carlos, St-Cyr Daniel J., Beauregard Kim, Bernard-Gauthier Vadim, Chemtob Sylvain, Lubell William D., Probing Anti-inflammatory Properties Independent of NF-κB Through Conformational Constraint of Peptide-Based Interleukin-1 Receptor Biased Ligands, Frontiers in Chemistry, 7, 2019. Crossref
-
Stefanucci Azzurra, Lei Wei, Pieretti Stefano, Novellino Ettore, Dimmito Marilisa Pia, Marzoli Francesca, Streicher John M., Mollica Adriano, On resin click-chemistry-mediated synthesis of novel enkephalin analogues with potent anti-nociceptive activity, Scientific Reports, 9, 1, 2019. Crossref
-
Huang He, Damjanovic Jovan, Miao Jiayuan, Lin Yu-Shan, Cyclic peptides: backbone rigidification and capability of mimicking motifs at protein–protein interfaces, Physical Chemistry Chemical Physics, 23, 1, 2021. Crossref
-
Jiang Yixiang, Liu Sha, Tian Gaofei, Cheung Hayden Jit Hei, Li Xin, Li Xiang David, Concise solid-phase synthesis enables derivatisation of YEATS domain cyclopeptide inhibitors for improved cellular uptake, Bioorganic & Medicinal Chemistry, 45, 2021. Crossref
-
Sindhikara Dan, Wagner Michael, Gkeka Paraskevi, Güssregen Stefan, Tiwari Garima, Hessler Gerhard, Yapici Engin, Li Ziyu, Evers Andreas, Automated Design of Macrocycles for Therapeutic Applications: From Small Molecules to Peptides and Proteins, Journal of Medicinal Chemistry, 63, 20, 2020. Crossref
-
Qvit Nir, Peptides and Peptidomimetics as Foundations for Drug Discovery, in Encyclopedia of Molecular Pharmacology, 2021. Crossref
-
Rubin Samuel J.S., Qvit Nir, Engineering “Antimicrobial Peptides” and Other Peptides to Modulate Protein-Protein Interactions in Cancer, Current Topics in Medicinal Chemistry, 20, 32, 2020. Crossref
-
Yip Chee-Hoo, Mahalingam Sobina, Wan Kiew-Lian, Nathan Sheila, Karunasagar Iddya, Prodigiosin inhibits bacterial growth and virulence factors as a potential physiological response to interspecies competition, PLOS ONE, 16, 6, 2021. Crossref
-
Zhang Yue, Zhang Qing, Wong Clarence T. T., Li Xuechen, Chemoselective Peptide Cyclization and Bicyclization Directly on Unprotected Peptides, Journal of the American Chemical Society, 141, 31, 2019. Crossref
-
Łepek Teresa, Kwiatkowska Anna, Couture Frédéric, Ly Kévin, Desjardins Roxane, Dory Yves, Prahl Adam, Day Robert, Macrocyclization of a potent PACE4 inhibitor: Benefits and limitations, European Journal of Cell Biology, 96, 5, 2017. Crossref
-
Jiwacharoenchai Nattanan, Tabtimmai Lueacha, Kiriwan Duangnapa, Suwattanasophon Chonticha, Seetaha Supaphorn, Sinthuvanich Chomdao, Choowongkomon Kiattawee, A novel cyclic NP1 reveals obstruction of EGFR kinase activity and attenuation of EGFR‐driven cell lines, Journal of Cellular Biochemistry, 123, 2, 2022. Crossref
-
Qvit Nir, Peptides and Peptidomimetics as Foundations for Drug Discovery, in Encyclopedia of Molecular Pharmacology, 2021. Crossref
-
Choi Yoona, Lee Subin, Kim Heejun, Park Seung Bum, Design and Synthesis of Conformationally Diverse Pyrimidine-Embedded Medium/Macro- and Bridged Cycles via Skeletal Transformation, Frontiers in Chemistry, 10, 2022. Crossref
-
Doller Dario, Allosteric Modulation, in Comprehensive Pharmacology, 2022. Crossref
-
Ullrich Sven, George Josemon, Coram Alexandra E., Morewood Richard, Nitsche Christoph, Biocompatible and Selective Generation of Bicyclic Peptides**, Angewandte Chemie International Edition, 2022. Crossref
-
Ullrich Sven, George Josemon, Coram Alexandra E., Morewood Richard, Nitsche Christoph, Biokompatible und selektive Generierung bizyklischer Peptide**, Angewandte Chemie, 2022. Crossref
-
Dias Susana A, Pinto Sandra N, Silva-Herdade Ana S, Cheneval Olivier, Craik David J, Coutinho Ana, Castanho Miguel A R B, Henriques Sónia T, Veiga Ana Salomé, A designed cyclic analogue of gomesin has potent activity against Staphylococcus aureus biofilms, Journal of Antimicrobial Chemotherapy, 2022. Crossref
-
Rubin Samuel J.S., Qvit Nir, Preface, in Peptide and Peptidomimetic Therapeutics, 2022. Crossref
-
Rubin Samuel J.S., Qvit Nir, The current state of backbone cyclic peptidomimetics and their application to drug discovery, in Peptide and Peptidomimetic Therapeutics, 2022. Crossref
-
Hanout Wessal, Qvit Nir, Antiparasitic therapeutic peptidomimetics, in Peptide and Peptidomimetic Therapeutics, 2022. Crossref
-
Qvit Nir, Therapeutic peptides targeting protein kinase: progress, challenges, and future directions, featuring cancer and cardiovascular disease, in Peptide and Peptidomimetic Therapeutics, 2022. Crossref